A CYP11B2 variant (rs7831617) is associated with lower blood pressure and a reduced risk of incident hypertension
Authors:
Open Access
- 3 July 2026
- journal article
- Published by Springer Nature in Scientific Reports
- Vol. 16 (1)
Abstract
Genetic variation contributes to interindividual differences in blood pressure regulation and the long-term risk of hypertension. CYP11B2, which encodes aldosterone synthase, is a key component of the renin‒angiotensin‒aldosterone system; however, longitudinal evidence linking common genetic variants near CYP11B2 to incident hypertension remains limited. We investigated genetic variation at the CYP11B2 locus in 8,840 participants from the Korean Genome and Epidemiology Study, a population-based cohort with up to 16 years of follow-up data. Following gene-centric screening, we identified rs7831617, a common noncoding variant located downstream of CYP11B2, with genotype frequencies of 46.4% (GG), 43.6% (GT), and 9.8% (TT). Associations of rs7831617 with baseline blood pressure, plasma renin concentrations, prevalent hypertension, and incident hypertension were examined via multivariable regression and discrete-time survival analyses. In addition, metabolomic profiling was conducted in a subset of participants to explore genotype-dependent metabolic differences. The rs7831617 T allele was nominally associated with higher plasma renin concentrations and a lower risk of incident hypertension during follow-up (adjusted hazard ratio 0.93, 95% confidence interval 0.88-0.99), whereas no association was observed with prevalent hypertension at baseline. Metabolomic profiling revealed no global genotype-dependent metabolic shifts, with only six metabolites (glutamate, alanine, asparagine, PC ae C34:1, PC ae C42:4, and PC ae C44:5) showing nominal associations with genotype. Although several clinical and metabolomic phenotypes showed nominal associations with rs7831617, none remained significant after correction for multiple testing. These findings suggest a potential association of rs7831617, a common noncoding variant adjacent to CYP11B2, with lower blood pressure and a reduced long-term risk of hypertension.Keywords
Funding Information
- National Research Foundation of Korea (RS-2023-00210819)
- the Daejeon and Chungcheong Branch of the Korean Endocrine Society
This publication has 27 references indexed in Scilit:
- The genetics of hypertensionNature Reviews Nephrology, 2025
- Renin-angiotensin-aldosterone system and its relation to hypertensionHypertension Research, 2025
- Genome-wide analysis in over 1 million individuals of European ancestry yields improved polygenic risk scores for blood pressure traitsNature Genetics, 2024
- The WHO Global report 2023 on hypertension warning the emerging hypertension burden in globe and its treatment strategyHypertension Research, 2024
- Decoding the mechanism of hypertension through multiomics profilingJournal of Human Hypertension, 2022
- A multi-omics study of circulating phospholipid markers of blood pressureScientific Reports, 2022
- Trans-ethnic meta-analysis identifies new loci associated with longitudinal blood pressure traitsScientific Reports, 2021
- Modulation of aldosterone levels by −344 C/T CYP11B2 polymorphism and spironolactone use in resistant hypertensionJournal of the American Society of Hypertension, 2014
- Reevaluation of the association of seven candidate genes with blood pressure and hypertension: a replication study and meta-analysis with a larger sample sizeHypertension Research, 2012
- Association between aldosterone synthase (CYP11B2) polymorphism and left ventricular mass in human essential hypertensionJACC, 2004